Treatment-induced downregulation of antiphospholipid antibodies: Effect of rituximab alone on clinical and laboratory features of antiphospholipid syndrome

Lupus

Volumn 20, Issue 10, 2011, Pages 1106-1108

  Sciascia, S ^a   Naretto, C ^a   Rossi, D ^a   Bazzan, M ^a   Roccatello, D ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; PHOSPHOLIPID ANTIBODY; PREDNISONE; RITUXIMAB;

ADULT; ANTICOAGULANT THERAPY; ANTIPHOSPHOLIPID SYNDROME; CASE REPORT; CLINICAL FEATURE; DOWN REGULATION; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG WITHDRAWAL; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LABORATORY DIAGNOSIS; LETTER; PRIORITY JOURNAL; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TREATMENT CONTRAINDICATION; TREATMENT RESPONSE;

ANTIBODIES, ANTIPHOSPHOLIPID; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTICOAGULANTS; ANTIPHOSPHOLIPID SYNDROME; DOWN-REGULATION; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; PLATELET COUNT; THROMBOCYTOPENIA; YOUNG ADULT;

EID: 80052883866     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203311400115     Document Type: Letter

References (10)

1. Exner T. Comparison of two simple tests for the lupus anticoagulant. Am J Clin Pathol. 1985 ; 83: 215-218 (Pubitemid 15128850)
2. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006 ; 4: 295-306
3. Roccatello D, Baldovino S, Rossi D, et al. Rituximab as a therapeutic tool in severe mixed cryoglobulinemia. Clin Rev Allergy Immunol. 2008 ; 34: 111-117
4. Satomi A, Koiwa F, Ogata H, et al. Plasma exchange for thrombocytopenia in antiphospholipid syndrome: a case report. Ther Apher. 1998 ; 2: 157-159 (Pubitemid 28311176)
5. Lim W, Crowther MA, Eikelboom JW. Management of antiphospholipid antibody syndrome: a systematic review. JAMA. 2006 ; 295: 1050-1057
6. Erre GL, Pardini S, Faedda R, Passiu G. Effect of rituximab on clinical and laboratory features of antiphospholipid syndrome: a case report and a review of literature. Lupus. 2008 ; 17: 50-50
7. Ioannou Y, Lambrianides A, Cambridge G, Leandro MJ, Edwards JC, Isenberg DA. B cell depletion therapy for patients with systemic lupus erythematosus results in a significant drop in anticardiolipin antibody titres. Ann Rheum Dis. 2008 ; 67: 425-426 (Pubitemid 351281283)
8. Vlachoyiannopoulos PG, Toya SP, Katsifis G, et al. Upregulation of antiphospholipid antibodies following cyclophosphamide therapy in patients with systemic lupus erythematosus. J Rheumatol. 2008 ; 35: 1768-1775
9. Rubenstein E, Arkfeld D, Metyas S, Shinada S, Ehresmann S, Liebman HA. Rituximab treatment for resistant antiphospholipid syndrome. J Rheumatol. 2006 ; 33: 355-357 (Pubitemid 43209314)
10. Erdozain JG, Ruiz-Irastorza G, Egurbide MV, Aguirre C. Sustained response to rituximab of autoimmune haemolytic anaemia associated with antiphospholipid syndrome. Haematologica. 2004 ; 89: ECR34 - ECR34